Joyce Laird

Serious Recall Involves Incompatible Defibrillator Electrodes

Posted in by Joyce Laird on October 19, 2016
There is apparently a dangerous connector incompatibility problem involving a Leonhard Lang defibrillation electrode.Joyce LairdFDA recently issued a Class I designation for Leonhard Lang's recall of its 50028 defibrillation electrode Skintact DF29N series.More than 8000 electrod... Continue

How Bad Are FDA Device Reporting Loopholes?

Posted in by Joyce Laird on October 19, 2016
Loopholes in the way medical device manufacturers report adverse events to FDA allow manufacturers to keep critical details under wraps, according to a new report. Joyce LairdMedical device adverse event reports are far from timely in the United States, according to a recent report by Joe Carls... Continue

Medtronic Scores Approval for MRI-Compatible Devices

Posted in by Joyce Laird on October 17, 2016
A new FDA approval allows patients with a wide range of Medtronic cardiac rhythm and heart failure devices to undergo MRI scans anywhere in their body.Joyce LairdMedtronic's leadless, transcatheter Micra pacemaker is among those covered by the approval. (Image courtesy of Medtronic)Medtronic receive... Continue

Titan Takes on Intuitive Surgical

Posted in by Joyce Laird on October 13, 2016
Titan Medical’s Sport surgical robotic system closely shadows Intuitive Surgical's DaVinci—but at a much lower cost.Joyce LairdTitan Medical, Canada and Ximedica LLC have infused new life into Titan’s Sport surgical system, which has been in process for the past several years. After many years... Continue

Joyce Laird

Posted by Joyce Laird on October 12, 2016

This Is How You 3-D Print Stents

Posted in by Joyce Laird on October 12, 2016
Customized implantable medical devices continue to advance—this time with flexible, 3-D printed stents designed for each patient’s specific needs.Joyce LairdMedical technology is pushing the 3-D printing envelope at the Northwestern McCormick School of Engineering, where researchers have created... Continue